Immune responses of macrophages and dendritic cells regulated by mTOR signalling

Biochemical Society Transactions

Volumn 41, Issue 4, 2013, Pages 927-933

  Katholnig, Karl ^a   Linke, Monika ^a   Pham, Ha ^a   Hengstschläger, Markus ^a   Weichhart, Thomas ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Cancer; Dendritic cell; Immune regulation; Macrophage; Mammalian target of rapamycin (mTOR)

Indexed keywords

CHEMOKINE; CYTOKINE; INTERFERON; MAMMALIAN TARGET OF RAPAMYCIN; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR;

ARTICLE; BONE MARROW CELL; DENDRITIC CELL; GRAFT RECIPIENT; HUMAN; IMMUNE RESPONSE; IMMUNITY; IN VIVO STUDY; INNATE IMMUNITY; KIDNEY TRANSPLANTATION; MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CYTOKINES; DENDRITIC CELLS; HUMANS; IMMUNITY, INNATE; INFLAMMATION MEDIATORS; MACROPHAGES; NEOPLASMS; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES;

EID: 84880532574     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST20130032     Document Type: Article

References (51)

1. Weichhart, T. (2012) Mammalian target of rapamycin: a signaling kinase for every aspect of cellular life. Methods Mol. Biol. 821, 1-14
2. Cornu, M., Albert, V. and Hall, M.N. (2013) mTOR in aging, metabolism, and cancer. Curr. Opin. Genet. Dev. 23, 53-62
3. Araki, K., Ellebedy, A.H. and Ahmed, R. (2011) TOR in the immune system. Curr. Opin. Cell Biol. 23, 707-715
4. Thomson, A.W., Turnquist, H.R. and Raimondi, G. (2009) Immunoregulatory functions of mTOR inhibition. Nat. Rev. Immunol. 9, 324-337
5. Weichhart, T. and Saemann, M.D. (2009) The multiple facets of mTOR in immunity. Trends Immunol. 30, 218-226
6. Powell, J.D., Pollizzi, K.N., Heikamp, E.B. and Horton, M.R. (2012) Regulation of immune responses by mTOR. Annu. Rev. Immunol. 30, 39-68
7. Chi, H. (2012) Regulation and function of mTOR signalling in T cell fate decisions. Nat. Rev. Immunol. 12, 325-338
8. Laplante, M. and Sabatini, D.M. (2012) mTOR signaling in growth control and disease. Cell 149, 274-293
9. Liu, Q., Thoreen, C., Wang, J., Sabatini, D. and Gray, N.S. (2009) mTOR mediated anti-cancer drug discovery. Drug Discovery Today: Ther. Strategies 6, 47-55
10. Weichhart, T., Costantino, G., Poglitsch, M., Rosner, M., Zeyda, M., Stuhlmeier, K.M., Kolbe, T., Stulnig, T.M., Horl, W.H., Hengstschlager, M. et al. (2008) The TSC-mTOR signaling pathway regulates the innate inflammatory response. Immunity 29, 565-577
11. Schmitz, F., Heit, A., Dreher, S., Eisenacher, K., Mages, J., Haas, T., Krug, A., Janssen, K.P., Kirschning, C.J. and Wagner, H. (2008) Mammalian target of rapamycin (mTOR) orchestrates the defense program of innate immune cells. Eur. J. Immunol. 38, 2981-2992
12. Weintz, G., Olsen, J.V., Fruhauf, K., Niedzielska, M., Amit, I., Jantsch, J., Mages, J., Frech, C., Dolken, L., Mann, M. et al. (2010) The phosphoproteome of Toll-like receptor-activated macrophages. Mol. Syst. Biol. 6, 371
13. Haidinger, M., Poglitsch, M., Geyeregger, R., Kasturi, S., Zeyda, M., Zlabinger, G.J., Pulendran, B., Horl, W.H., Saemann, M.D. and Weichhart, T. (2010) A versatile role of mammalian target of rapamycin in human dendritic cell function and differentiation. J. Immunol. 185, 3919-3931
14. Sathaliyawala, T., O'Gorman, W.E., Greter, M., Bogunovic, M., Konjufca, V., Hou, Z.E., Nolan, G.P., Miller, M.J., Merad, M. and Reizis, B. (2010) Mammalian target of rapamycin controls dendritic cell development downstream of Flt3 ligand signaling. Immunity 33, 597-606
15. Kellersch, B. and Brocker, T. (2013) Langerhans cell homeostasis in mice is dependent on mTORC1 but not mTORC2 function. Blood 121, 298-307
16. van de Laar, L., Buitenhuis, M., Wensveen, F.M., Janssen, H.L., Coffer, P.J. and Woltman, A.M. (2010) Human CD34-derived myeloid dendritic cell development requires intact phosphatidylinositol 3-kinase-protein kinase B-mammalian target of rapamycin signaling. J. Immunol. 184, 6600-6611
17. van de Laar, L., van den Bosch, A., Boonstra, A., Binda, R.S., Buitenhuis, M., Janssen, H.L., Coffer, P.J. and Woltman, A.M. (2012) PI3K-PKB hyperactivation augments human plasmacytoid dendritic cell development and function. Blood 120, 4982-4991
18. Turnquist, H.R., Raimondi, G., Zahorchak, A.F., Fischer, R.T., Wang, Z. and Thomson, A.W. (2007) Rapamycin-conditioned dendritic cells are poor stimulators of allogeneic CD4+ T cells, but enrich for antigen-specific Foxp3+ T regulatory cells and promote organ transplant tolerance. J. Immunol. 178, 7018-7031
19. Fukao, T., Tanabe, M., Terauchi, Y., Ota, T., Matsuda, S., Asano, T., Kadowaki, T., Takeuchi, T. and Koyasu, S. (2002) PI3K-mediated negative feedback regulation of IL-12 production in DCs. Nat. Immunol. 3, 875-881
20. Ohtani, M., Nagai, S., Kondo, S., Mizuno, S., Nakamura, K., Tanabe, M., Takeuchi, T., Matsuda, S. and Koyasu, S. (2008) Mammalian target of rapamycin and glycogen synthase kinase 3 differentially regulate lipopolysaccharide- induced interleukin-12 production in dendritic cells. Blood 112, 635-643
21. Weichhart, T., Haidinger, M., Katholnig, K., Kopecky, C., Poglitsch, M., Lassnig, C., Rosner, M., Zlabinger, G.J., Hengstschlager, M., Muller, M. et al. (2011) Inhibition of mTOR blocks the anti-inflammatory effects of glucocorticoids in myeloid immune cells. Blood 117, 4273-4283
22. Turnquist, H.R., Cardinal, J., Macedo, C., Rosborough, B.R., Sumpter, T.L., Geller, D.A., Metes, D. and Thomson, A.W. (2010) mTOR and GSK-3 shape the CD4+ T-cell stimulatory and differentiation capacity of myeloid DCs after exposure to LPS. Blood 115, 4758-4769
23. Jiang, Q., Weiss, J.M., Back, T., Chan, T., Ortaldo, J.R., Guichard, S. and Wiltrout, R.H. (2011) mTOR kinase inhibitor AZD8055 enhances the immunotherapeutic activity of an agonist CD40 antibody in cancer treatment. Cancer Res. 71, 4074-4084
24. Chen, W., Ma, T., Shen, X.N., Xia, X.F., Xu, G.D., Bai, X.L. and Liang, T.B. (2012) Macrophage-induced tumor angiogenesis is regulated by the TSC2-mTOR pathway. Cancer Res. 72, 1363-1372
25. Cheekatla, S.S., Aggarwal, A. and Naik, S. (2012) mTOR signaling pathway regulates the IL-12/IL-10 axis in Leishmania donovani infection. Med. Microbiol. Immunol. 201, 37-46
26. Foey, A., Green, P., Foxwell, B., Feldmann, M. and Brennan, F. (2002) Cytokine-stimulated T cells induce macrophage IL-10 production dependent on phosphatidylinositol 3-kinase and p70S6K: implications for rheumatoid arthritis. Arthritis Res. 4, 64-70
27. Ohtani, M., Hoshii, T., Fujii, H., Koyasu, S., Hirao, A. and Matsuda, S. (2012) Cutting Edge: mTORC1 in intestinal CD11c+ CD11b+ dendritic cells regulates intestinal homeostasis by promoting IL-10 production. J. Immunol. 188, 4736-4740
28. Baker, A.K., Wang, R., Mackman, N. and Luyendyk, J.P. (2009) Rapamycin enhances LPS induction of tissue factor and tumor necrosis factor-α expression in macrophages by reducing IL-10 expression. Mol. Immunol. 46, 2249-2255
29. Hedl, M. and Abraham, C. (2011) Secretory mediators regulate Nod2-induced tolerance in human macrophages. Gastroenterology 140, 231-241
30. Yoshida, T., Mett, I., Bhunia, A.K., Bowman, J., Perez, M., Zhang, L., Gandjeva, A., Zhen, L., Chukwueke, U., Mao, T. et al. (2010) Rtp801, a suppressor of mTOR signaling, is an essential mediator of cigarette smoke-induced pulmonary injury and emphysema. Nat. Med. 16, 767-773
31. Li, X., Han, X., Llano, J., Bole, M., Zhou, X., Swan, K., Anandaiah, A., Nelson, B., Patel, N.R., Reinach, P.S. et al. (2011) Mammalian target of rapamycin inhibition in macrophages of asymptomatic HIV+ persons reverses the decrease in TLR-4-mediated TNF-α release through prolongation of MAPK pathway activation. J. Immunol. 187, 6052-6058
32. Blanchet, F.P., Moris, A., Nikolic, D.S., Lehmann, M., Cardinaud, S., Stalder, R., Garcia, E., Dinkins, C., Leuba, F., Wu, L. et al. (2010) Human immunodeficiency virus-1 inhibition of immunoamphisomes in dendritic cells impairs early innate and adaptive immune responses. Immunity 32, 654-669
33. Brown, J., Wang, H., Suttles, J., Graves, D.T. and Martin, M. (2011) Mammalian target of rapamycin complex 2 (mTORC2) negatively regulates Toll-like receptor 4-mediated inflammatory response via FoxO1. J. Biol. Chem. 286, 44295-44305
34. Fan, W., Morinaga, H., Kim, J.J., Bae, E., Spann, N.J., Heinz, S., Glass, C.K. and Olefsky, J.M. (2010) FoxO1 regulates Tlr4 inflammatory pathway signalling in macrophages. EMBO J. 29, 4223-4236
35. Pan, H., O'Brien, T.F., Zhang, P. and Zhong, X.P. (2012) The role of tuberous sclerosis complex 1 in regulating innate immunity. J. Immunol. 188, 3658-3666
36. Huang, J., Dibble, C.C., Matsuzaki, M. and Manning, B.D. (2008) The TSC1-TSC2 complex is required for proper activation of mTOR complex 2. Mol. Cell. Biol. 28, 4104-4115
37. Brouard, S., Puig-Pey, I., Lozano, J.J., Pallier, A., Braud, C., Giral, M., Guillet, M., Londoño, M.C., Oppenheimer, F., Campistol, J.M. et al. (2010) Comparative transcriptional and phenotypic peripheral blood analysis of kidney recipients under cyclosporin A or sirolimus monotherapy. Am. J. Transplant. 10, 2604-2614
38. Saemann, M.D., Haidinger, M., Hecking, M., Horl, W.H. and Weichhart, T. (2009) The multifunctional role of mTOR in innate immunity: implications for transplant immunity. Am. J. Transplant. 9, 2655-2661
39. Buron, F., Malvezzi, P., Villar, E., Chauvet, C., Janbon, B., Denis, L., Brunet, M., Daoud, S., Cahen, R., Pouteil-Noble, C. et al. (2013) Profiling sirolimus-induced inflammatory syndrome: a prospective tricentric observational study. PLoS ONE 8, e53078
40. Kirsch, A.H., Riegelbauer, V., Tagwerker, A., Rudnicki, M., Rosenkranz, A.R. and Eller, K. (2012) The mTOR-inhibitor rapamycin mediates proteinuria in nephrotoxic serum nephritis by activating the innate immune response. Am. J. Physiol. Renal Physiol. 303, F569-F575
41. Poglitsch, M., Weichhart, T., Hecking, M., Werzowa, J., Katholnig, K., Antlanger, M., Krmpotic, A., Jonjic, S., Horl, W.H., Zlabinger, G.J. et al. (2012) CMV late phase-induced mTOR activation is essential for efficient virus replication in polarized human macrophages. Am. J. Transplant. 12, 1458-1468
42. Buchkovich, N.J., Yu, Y., Zampieri, C.A. and Alwine, J.C. (2008) The TORrid affairs of viruses: effects of mammalian DNA viruses on the PI3K-Akt-mTOR signalling pathway. Nat. Rev. Microbiol. 6, 266-275
43. Williams, D.L., Li, C., Ha, T., Ozment-Skelton, T., Kalbfleisch, J.H., Preiszner, J., Brooks, L., Breuel, K. and Schweitzer, J.B. (2004) Modulation of the phosphoinositide 3-kinase pathway alters innate resistance to polymicrobial sepsis. J. Immunol. 172, 449-456
44. Martin, M., Schifferle, R.E., Cuesta, N., Vogel, S.N., Katz, J. and Michalek, S.M. (2003) Role of the phosphatidylinositol 3 kinase-Akt pathway in the regulation of IL-10 and IL-12 by Porphyromonas gingivalis lipopolysaccharide. J. Immunol. 171, 717-725
45. Katholnig, K., Kaltenecker, C.C., Hayakawa, H., Rosner, M., Lassnig, C., Zlabinger, G.J., Gaestel, M., Muller, M., Hengstschlager, M., Horl, W.H. et al. (2013) p38α senses environmental stress to control innate immune responses via mechanistic target of rapamycin. J. Immunol. 190, 1519-1527
46. Lopez-Pelaez, M., Soria-Castro, I., Bosca, L., Fernandez, M. and Alemany, S. (2011) Cot/tpl2 activity is required for TLR-induced activation of the Akt p70 S6k pathway in macrophages: implications for NO synthase 2 expression. Eur. J. Immunol. 41, 1733-1741
47. Lopez-Pelaez, M., Fumagalli, S., Sanz, C., Herrero, C., Guerra, S., Fernandez, M. and Alemany, S. (2012) Cot/tpl2-MKK1/2-Erk1/2 controls mTORC1-mediated mRNA translation in Toll-like receptor-activated macrophages. Mol. Biol. Cell 23, 2982-2992
48. Colina, R., Costa-Mattioli, M., Dowling, R.J., Jaramillo, M., Tai, L.H., Breitbach, C.J., Martineau, Y., Larsson, O., Rong, L., Svitkin, Y.V. et al. (2008) Translational control of the innate immune response through IRF-7. Nature 452, 323-328
49. Jaramillo, M., Gomez, M.A., Larsson, O., Shio, M.T., Topisirovic, I., Contreras, I., Luxenburg, R., Rosenfeld, A., Colina, R., McMaster, R.W. et al. (2011) Leishmania repression of host translation through mTOR cleavage is required for parasite survival and infection. Cell Host Microbe 9, 331-341
50. Jagannath, C., Lindsey, D.R., Dhandayuthapani, S., Xu, Y., Hunter, Jr, R.L. and Eissa, N.T. (2009) Autophagy enhances the efficacy of BCG vaccine by increasing peptide presentation in mouse dendritic cells. Nat. Med. 15, 267-276
51. Amiel, E., Everts, B., Freitas, T.C., King, I.L., Curtis, J.D., Pearce, E.L. and Pearce, E.J. (2012) Inhibition of mechanistic target of rapamycin promotes dendritic cell activation and enhances therapeutic autologous vaccination in mice. J. Immunol 189, 2151-2158